David Low
Stock Analyst at UBS
(2.77)
# 2,730
Out of 4,429 analysts
287
Total ratings
48.1%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: COH Cochlear Limited | Maintained: Hold | $106.00 | $113.07 | -6.25% | 19 | Jun 15, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $21.10 → $19.60 | $19.93 | -1.66% | 31 | Jun 15, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $175.00 → $158.00 | $115.56 | +36.73% | 27 | Jun 9, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.90 | $39.56 | +8.44% | 20 | May 28, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | n/a | $27.06 | - | 24 | Apr 28, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $36.00 → $35.60 | $30.16 | +18.04% | 15 | Feb 16, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Downgraded: Hold | $16.50 | $14.78 | +11.64% | 3 | Aug 31, 2025 | |
| ASX: PNV PolyNovo Limited | Maintained: Hold | $1.30 | $0.96 | +35.42% | 1 | Aug 27, 2025 | |
| NZE: EBO EBOS Group Limited | Maintained: Hold | $47.08 → $44.63 | $20.56 | +117.07% | 3 | Aug 27, 2025 | |
| ASX: NAN Nanosonics Limited | Maintained: Sell | $4.00 → $3.90 | $3.28 | +19.08% | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.25 → $3.40 | $1.93 | +76.44% | 12 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.62 | $0.36 | +72.22% | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7.10 → $8.00 | $6.20 | +29.14% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $282.00 → $300.00 | $172.65 | +73.76% | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $290 → $310 | $188.45 | +64.50% | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 32.00 → 35.00 | $37.93 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.95 → $0.78 | $0.295 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.91 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $19.87 | n/a | 1 | Dec 4, 2019 |
Cochlear Limited
Jun 15, 2026
Maintained: Hold
Price Target: $106.00
Current: $113.07
Upside: -6.25%
Sonic Healthcare Limited
Jun 15, 2026
Maintained: Hold
Price Target: $21.10 → $19.60
Current: $19.93
Upside: -1.66%
CSL Limited
Jun 9, 2026
Maintained: Buy
Price Target: $175.00 → $158.00
Current: $115.56
Upside: +36.73%
Ramsay Health Care Limited
May 28, 2026
Maintained: Hold
Price Target: $42.90
Current: $39.56
Upside: +8.44%
ResMed Inc.
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $27.06
Upside: -
Ansell Limited
Feb 16, 2026
Maintained: Hold
Price Target: $36.00 → $35.60
Current: $30.16
Upside: +18.04%
Telix Pharmaceuticals Limited
Aug 31, 2025
Downgraded: Hold
Price Target: $16.50
Current: $14.78
Upside: +11.64%
PolyNovo Limited
Aug 27, 2025
Maintained: Hold
Price Target: $1.30
Current: $0.96
Upside: +35.42%
EBOS Group Limited
Aug 27, 2025
Maintained: Hold
Price Target: $47.08 → $44.63
Current: $20.56
Upside: +117.07%
Nanosonics Limited
Aug 27, 2025
Maintained: Sell
Price Target: $4.00 → $3.90
Current: $3.28
Upside: +19.08%
Aug 27, 2025
Maintained: Buy
Price Target: $3.25 → $3.40
Current: $1.93
Upside: +76.44%
Aug 25, 2025
Maintained: Sell
Price Target: $0.62
Current: $0.36
Upside: +72.22%
Aug 18, 2025
Downgraded: Hold
Price Target: $7.10 → $8.00
Current: $6.20
Upside: +29.14%
Aug 14, 2025
Maintained: Hold
Price Target: $282.00 → $300.00
Current: $172.65
Upside: +73.76%
Aug 1, 2025
Maintained: Buy
Price Target: $290 → $310
Current: $188.45
Upside: +64.50%
Jun 3, 2025
Maintained: Hold
Price Target: 32.00 → 35.00
Current: $37.93
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $0.95 → $0.78
Current: $0.295
Upside: n/a
Aug 23, 2021
Maintained: Hold
Price Target: n/a
Current: $13.91
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $19.87
Upside: n/a